Trinity Biotech (TRIB) Current Leases (2016 - 2025)
Trinity Biotech's Current Leases history spans 10 years, with the latest figure at $2.6 million for Q4 2025.
- On a quarterly basis, Current Leases rose 13.26% to $2.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 13.26% increase, with the full-year FY2025 number at $2.6 million, up 13.26% from a year prior.
- Current Leases hit $2.6 million in Q4 2025 for Trinity Biotech, up from $2.3 million in the prior quarter.
- Over the last five years, Current Leases for TRIB hit a ceiling of $2.6 million in Q4 2025 and a floor of $1.7 million in Q4 2022.
- Historically, Current Leases has averaged $2.0 million across 5 years, with a median of $2.0 million in 2021.
- Biggest five-year swings in Current Leases: decreased 15.35% in 2022 and later soared 34.89% in 2024.
- Tracing TRIB's Current Leases over 5 years: stood at $2.0 million in 2021, then decreased by 15.35% to $1.7 million in 2022, then rose by 1.07% to $1.7 million in 2023, then surged by 34.89% to $2.3 million in 2024, then increased by 13.26% to $2.6 million in 2025.
- Business Quant data shows Current Leases for TRIB at $2.6 million in Q4 2025, $2.3 million in Q4 2024, and $1.7 million in Q4 2023.